Orbimed Advisors as of June 30, 2017
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 135 positions in its portfolio as reported in the June 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Alexion Pharmaceuticals | 4.9 | $471M | 3.9M | 121.67 | |
Celgene Corporation | 4.7 | $445M | 3.4M | 129.87 | |
Biogen Idec (BIIB) | 4.6 | $442M | 1.6M | 271.36 | |
Boston Scientific Corporation (BSX) | 4.2 | $399M | 14M | 27.72 | |
Merck & Co (MRK) | 3.7 | $352M | 5.5M | 64.09 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.7 | $261M | 2.0M | 128.87 | |
Eli Lilly & Co. (LLY) | 2.6 | $253M | 3.1M | 82.30 | |
Wright Medical Group Nv | 2.6 | $246M | 8.9M | 27.49 | |
Regeneron Pharmaceuticals (REGN) | 2.4 | $229M | 467k | 491.14 | |
Agilent Technologies Inc C ommon (A) | 2.4 | $226M | 3.8M | 59.31 | |
Amgen (AMGN) | 2.4 | $224M | 1.3M | 172.23 | |
Edwards Lifesciences (EW) | 2.3 | $218M | 1.8M | 118.24 | |
Puma Biotechnology (PBYI) | 2.2 | $212M | 2.4M | 87.40 | |
Incyte Corporation (INCY) | 2.2 | $209M | 1.7M | 125.91 | |
CIGNA Corporation | 2.1 | $205M | 1.2M | 167.39 | |
Clovis Oncology | 2.1 | $197M | 2.1M | 93.63 | |
Humana (HUM) | 1.9 | $186M | 771k | 240.62 | |
Anthem (ELV) | 1.8 | $173M | 921k | 188.13 | |
Abbvie (ABBV) | 1.7 | $159M | 2.2M | 72.51 | |
Johnson & Johnson (JNJ) | 1.6 | $149M | 1.1M | 132.29 | |
Gilead Sciences (GILD) | 1.5 | $147M | 2.1M | 70.78 | |
Loxo Oncology | 1.4 | $139M | 1.7M | 80.19 | |
Aetna | 1.4 | $135M | 888k | 151.83 | |
Array BioPharma | 1.2 | $119M | 14M | 8.37 | |
Mylan Nv | 1.2 | $116M | 3.0M | 38.82 | |
Ironwood Pharmaceuticals (IRWD) | 1.1 | $109M | 5.8M | 18.88 | |
Intercept Pharmaceuticals In | 1.1 | $104M | 857k | 121.07 | |
Jazz Pharmaceuticals (JAZZ) | 1.1 | $100M | 646k | 155.50 | |
Aerie Pharmaceuticals | 1.0 | $96M | 1.8M | 52.55 | |
Synergy Pharmaceuticals | 1.0 | $94M | 21M | 4.45 | |
Thermo Fisher Scientific (TMO) | 1.0 | $93M | 534k | 174.47 | |
Ascendis Pharma A S (ASND) | 1.0 | $94M | 3.4M | 27.76 | |
Audentes Therapeutics | 1.0 | $92M | 4.8M | 19.13 | |
Shire | 0.9 | $91M | 549k | 165.27 | |
Allergan | 0.9 | $91M | 374k | 243.09 | |
BioMarin Pharmaceutical (BMRN) | 0.9 | $89M | 983k | 90.82 | |
Magellan Health Services | 0.9 | $89M | 1.2M | 72.90 | |
Pfizer (PFE) | 0.9 | $83M | 2.5M | 33.59 | |
UnitedHealth (UNH) | 0.8 | $80M | 429k | 185.42 | |
Insys Therapeutics | 0.8 | $78M | 6.2M | 12.65 | |
Medtronic (MDT) | 0.8 | $78M | 879k | 88.75 | |
Allergan Plc pfd conv ser a | 0.8 | $77M | 88k | 867.41 | |
Insmed (INSM) | 0.8 | $75M | 4.4M | 17.16 | |
Mallinckrodt Pub | 0.8 | $75M | 1.7M | 44.81 | |
Glaukos (GKOS) | 0.8 | $72M | 1.7M | 41.47 | |
Illumina (ILMN) | 0.7 | $69M | 399k | 173.52 | |
Corvus Pharmaceuticals (CRVS) | 0.7 | $65M | 5.4M | 12.10 | |
Viewray (VRAYQ) | 0.6 | $61M | 9.5M | 6.47 | |
Achillion Pharmaceuticals | 0.6 | $60M | 13M | 4.59 | |
Global Blood Therapeutics In | 0.6 | $59M | 2.2M | 27.35 | |
Beigene | 0.6 | $58M | 1.3M | 45.00 | |
Select Medical Holdings Corporation (SEM) | 0.6 | $57M | 3.7M | 15.35 | |
Gw Pharmaceuticals Plc ads | 0.6 | $56M | 561k | 100.25 | |
Immunomedics Inc note 4.750% 2/1 | 0.6 | $55M | 30M | 1.83 | |
Hca Holdings (HCA) | 0.6 | $52M | 597k | 87.20 | |
Alnylam Pharmaceuticals (ALNY) | 0.5 | $51M | 639k | 79.76 | |
Bristol Myers Squibb (BMY) | 0.5 | $49M | 875k | 55.72 | |
Intuitive Surgical (ISRG) | 0.5 | $45M | 48k | 935.37 | |
Stryker Corporation (SYK) | 0.5 | $44M | 316k | 138.78 | |
Immunomedics | 0.5 | $44M | 4.9M | 8.83 | |
Intellia Therapeutics (NTLA) | 0.5 | $43M | 2.7M | 16.00 | |
Bluebird Bio (BLUE) | 0.4 | $42M | 400k | 105.05 | |
Dermira | 0.4 | $41M | 1.4M | 29.14 | |
Nabriva Therapeutics | 0.4 | $41M | 3.9M | 10.48 | |
Nevro (NVRO) | 0.4 | $39M | 526k | 74.43 | |
Pieris Pharmaceuticals | 0.4 | $37M | 7.3M | 5.06 | |
Selecta Biosciences | 0.4 | $37M | 1.8M | 19.86 | |
Envision Healthcare | 0.4 | $36M | 578k | 62.67 | |
Momenta Pharmaceuticals | 0.4 | $36M | 2.1M | 16.90 | |
eHealth (EHTH) | 0.4 | $35M | 1.8M | 18.80 | |
Radius Health | 0.3 | $32M | 704k | 45.23 | |
Otonomy | 0.3 | $29M | 1.6M | 18.85 | |
ImmunoGen | 0.3 | $28M | 3.9M | 7.11 | |
Juno Therapeutics | 0.3 | $27M | 915k | 29.89 | |
Steadymed | 0.3 | $27M | 4.2M | 6.30 | |
Iovance Biotherapeutics (IOVA) | 0.3 | $25M | 3.4M | 7.45 | |
Integra LifeSciences Holdings (IART) | 0.2 | $23M | 427k | 54.51 | |
Galapagos Nv- (GLPG) | 0.2 | $22M | 284k | 76.52 | |
Obseva Sa | 0.2 | $22M | 2.6M | 8.55 | |
Sinovac Biotech | 0.2 | $18M | 2.7M | 6.75 | |
Assembly Biosciences | 0.2 | $18M | 888k | 20.65 | |
Dbv Technologies S A | 0.2 | $18M | 513k | 35.71 | |
Immunogen Inc bond | 0.2 | $18M | 10M | 1.83 | |
Teva Pharmaceutical Industries (TEVA) | 0.2 | $18M | 526k | 33.22 | |
Vanda Pharmaceuticals (VNDA) | 0.2 | $16M | 968k | 16.30 | |
Xencor (XNCR) | 0.2 | $16M | 747k | 21.11 | |
Cti Biopharma | 0.2 | $17M | 5.0M | 3.31 | |
Coherus Biosciences (CHRS) | 0.2 | $16M | 1.1M | 14.35 | |
Novus Therapeutics | 0.2 | $15M | 2.5M | 5.85 | |
Natera (NTRA) | 0.1 | $14M | 1.3M | 10.86 | |
Neurocrine Biosciences (NBIX) | 0.1 | $13M | 285k | 46.00 | |
Newlink Genetics Corporation | 0.1 | $14M | 1.8M | 7.35 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $12M | 2.3M | 5.20 | |
Aegerion Pharmaceuticals 2% Du cvbond | 0.1 | $12M | 15M | 0.82 | |
Wright Medical Group Rtsn V | 0.1 | $13M | 8.7M | 1.46 | |
Aurinia Pharmaceuticals (AUPH) | 0.1 | $11M | 1.8M | 6.13 | |
Argenx Se (ARGX) | 0.1 | $11M | 500k | 21.21 | |
AstraZeneca (AZN) | 0.1 | $8.5M | 250k | 34.09 | |
Alkermes (ALKS) | 0.1 | $8.4M | 145k | 57.97 | |
Heron Therapeutics (HRTX) | 0.1 | $9.0M | 650k | 13.85 | |
Adaptimmune Therapeutics (ADAP) | 0.1 | $8.6M | 1.9M | 4.49 | |
Dimension Therapeutics | 0.1 | $7.8M | 5.4M | 1.45 | |
Verona Pharma Plc ads (VRNA) | 0.1 | $7.8M | 667k | 11.66 | |
Zimmer Holdings (ZBH) | 0.1 | $6.3M | 49k | 128.41 | |
D Fluidigm Corp Del (LAB) | 0.1 | $7.1M | 1.7M | 4.04 | |
Fluidigm Corporation convertible cor | 0.1 | $6.3M | 10M | 0.63 | |
Syndax Pharmaceuticals (SNDX) | 0.1 | $6.1M | 437k | 13.97 | |
Aeglea Biotherapeutics | 0.1 | $5.7M | 1.5M | 3.85 | |
Crispr Therapeutics (CRSP) | 0.1 | $6.0M | 372k | 16.02 | |
NuVasive | 0.1 | $5.0M | 66k | 76.92 | |
Halozyme Therapeutics (HALO) | 0.1 | $4.5M | 350k | 12.82 | |
Infinity Pharmaceuticals (INFIQ) | 0.1 | $5.1M | 3.3M | 1.57 | |
Redhill Biopharma Ltd cmn | 0.1 | $4.9M | 565k | 8.62 | |
Sientra | 0.1 | $4.7M | 483k | 9.72 | |
Invitae (NVTAQ) | 0.1 | $4.4M | 457k | 9.56 | |
Sierra Oncology | 0.1 | $4.3M | 3.7M | 1.17 | |
Valeant Pharmaceuticals Int | 0.0 | $3.4M | 195k | 17.30 | |
Tesaro | 0.0 | $4.2M | 30k | 139.86 | |
Glycomimetics (GLYC) | 0.0 | $3.8M | 338k | 11.16 | |
Affimed Therapeutics B V | 0.0 | $3.7M | 1.8M | 2.05 | |
Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.0 | $4.3M | 7.0M | 0.61 | |
Minerva Neurosciences | 0.0 | $3.0M | 344k | 8.85 | |
Orexigen Therapeutics Inc note 2.750%12/0 | 0.0 | $2.4M | 5.2M | 0.47 | |
Xenon Pharmaceuticals (XENE) | 0.0 | $2.0M | 635k | 3.15 | |
Cellectis S A (CLLS) | 0.0 | $1.7M | 67k | 25.82 | |
Roka Bioscience | 0.0 | $2.3M | 894k | 2.58 | |
Amarin Corporation (AMRN) | 0.0 | $826k | 205k | 4.03 | |
Biolinerx Ltd-spons | 0.0 | $883k | 1.0M | 0.85 | |
Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.0 | $555k | 500k | 1.11 | |
Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.0 | $600k | 500k | 1.20 | |
Marinus Pharmaceuticals | 0.0 | $778k | 568k | 1.37 | |
Noveliontherapeuti.. | 0.0 | $923k | 100k | 9.23 | |
Alimera Sciences | 0.0 | $348k | 250k | 1.39 | |
Xtant Med Holdings | 0.0 | $314k | 475k | 0.66 | |
Medigus Ltd sponsord | 0.0 | $131k | 60k | 2.18 |